- Walton Centre for Neurology and Neurosurgery at the University of Liverpool, UK
- Not Clearly Pro or Con to the question "Should Marijuana Be a Medical Option?"
“BACKGROUND: Central pain in multiple sclerosis (MS) is common and often refractory to treatment…
CONCLUSIONS: Cannabis-based medicine [Sativex] is effective in reducing pain and sleep disturbance in patients with multiple sclerosis related central neuropathic pain and is mostly well tolerated.”
“Randomized, Controlled Trial of Cannabis-Based Medicine in Central Pain in Multiple Sclerosis,” Neurology, Sep. 2005
- Theoretical Expertise Ranking:
Individuals and organizations that do not fit into the other star categories.
- Involvement and Affiliations:
- Walton Centre for Neurology and Neurosurgery, University of Liverpool, UK
- Recipient, the Whitaker Prize for MS Research for “An RCT with Open-label Extension of Sativex, a Cannabis-Based Medicine (CBM), in MS-related Central Pain,” 2006
- Presenter of “Double Blind, Randomised, Parallel Group Placebo Controlled Study of Sativex in Central Neuropathic Pain in MS” to the American Pain Society on March-April 2005 in Boston, and to the 19th Congress of the European Committees for Treatment and Research in Multiple Sclerosis (ECTRIMS), Milan, Sep. 2003
- Co-presenter of “Variability in the Qualities of Chronic Neuropathic Pain in Multiple Sclerosis Assessed by the Neuropathic Pain Scale (NPS)” and “Burden of Neuropathic Pain in MS” to the American and European Committees for Treatment and Research in Multiple Sclerosis (ACTIMS-ECTRIMS), Maryland, Sep. 2002
- BMBS (Bachelor of Medicine and Bachelor of Surgery), school unknown
- None found